Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) announces that on June 23, 2025, following the market close, it entered into an Agreement and Plan of Merger (the “Merger Agreement”) to be acquired by Battery Ventures, a global, technology-focused investment firm, through its newly formed entity Bethpage Parent, Inc. (the “Acquirer”). Under the terms of the Merger Agreement, Battery will acquire Enzo for $0.70 per share in cash, representing a total consideration of approximately $37 million. Enzo Biochem, Inc. has operated as a life sciences company for over 45 years. The primary business of Enzo today is conducted through its Life Sciences division, Enzo Life Sciences, which focuses on labeling and detection technologies from DNA to whole cell analysis.
Read the full article: Enzo Biochem, Inc. to Be Acquired by Battery Ventures in All-Cash Transaction //
Source: https://www.globenewswire.com/news-release/2025/06/24/3104095/0/en/Enzo-Biochem-Inc-To-be-Acquired-by-Battery-Ventures-in-All-Cash-Transaction.html